Odyssey Software Ecosystem

About Stereotaxis

Stereotaxis is a leader in robotic technology for interventional medicine, specifically targeting complex cardiac ablation procedures for arrhythmias. The company's proprietary platform utilizes computer-controlled magnetic fields to remotely navigate catheters with sub-millimeter precision within the heart, aiming to improve procedural outcomes and reduce radiation exposure for both patients and physicians. While historically public and listed on the NYSE American, its operational and innovation hub is in Eindhoven. Its business model revolves around capital equipment sales of its robotic systems and recurring revenue from disposable instruments and services.

Therapeutic Areas